Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Portable Heart Boxes Enables Safer Transplantation

By HospiMedica International staff writers
Posted on 23 Jun 2020
A portable non-ischemic heart preservation (NIHP) device facilitates ground and airborne transportation of human hearts, according to a new study.

Researchers at Lund University (LU; Sweden) and Skåne University Hospital (Skåne; Malmö, Sweden) conducted a prospective, open-label, phase II study comparing NIHP to static cold preservation (SCS) in 31 adult recipients on waiting lists for heart transplantation; of these, six were assigned to NIHP and 25 to SCS. More...
NIHP was scheduled in advance, based on availability of trained team members. The primary endpoint was a composite of survival free of severe primary graft dysfunction, extracorporeal membrane oxygenation (ECMO) use within seven days, and acute cellular rejection within six months.

The results showed median preservation time was 223 minutes for NIHP and 194 minutes for SCS. Over the first six months, all of the patients assigned to NIHP achieved event-free survival, compared to 18 of those assigned to SCS (72%); these included four deaths and three cardiac-related adverse events. In addition, creatine kinase myocardial band (CK-MB) level assessed six hours after ending perfusion was 76 ng/mL for NIHP, compared with 138 ng/mL for SCS. The study was published on June 12, 2020, in Nature Communications.

“Our study shows that the new method enables longer preservation than today. If we, in our continued research, can establish that this is possible, it would mean entirely new opportunities for transplants. It would, for example, be possible to fly hearts between countries, which we are currently cannot,” said lead author Professor Johan Nilsson, MD, of LU and Skåne. “Although it is too early to draw far-reaching conclusions, we are obviously hopeful. If our results continue to be positive, the method could make a big difference for patients needing a heart transplant.”

The cornerstone of organ preservation has been SCS, which is ischemic. Although SCS reduces the extent of organ damage during transport, significant deterioration of the donated organ still occurs; the longer the organ is kept on ice, the greater the damage. During NIHP, in contrast, the heart is continuously perfused with a cold (8 °C) oxygenated cardioplegic nutrition–hormone solution containing erythrocytes. It is estimated that 60-65% of donor hearts globally cannot ultimately be used for transplantation due to the limitations of cold storage.

Related Links:
Lund University
Skåne University Hospital



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.